share_log

Actinium Signs Cooperative Research and Development Agreement With National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies

Actinium Signs Cooperative Research and Development Agreement With National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies

與美國國家癌症研究所簽署合作研發協議,進一步加強用於治療急性髓細胞白血病和其他血液系統惡性腫瘤的臨床和非臨床開發 Actimab-A
Benzinga Real-time News ·  2023/02/06 07:34

Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute to Further Enhance Clinical and Non-clinical Development of Actimab-A for the Treatment of Acute Myeloid Leukemia and Other Hematologic Malignancies

與美國國家癌症研究所簽訂合作研發協議,進一步加強 Actimab-A 用於治療急性髓細胞白血病和其他血液系統惡性腫瘤的臨床和非臨床開發

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論